Decision: Favourable
Study Title:
HORIZON: A PHASE II, OPEN-LABEL, OUTCOMES-ASSESSOR MASKED, MULTICENTRE, RANDOMISED, CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TWO DOSES OF GT005 ADMINISTERED AS A SINGLE SUBRETINAL INJECTION IN SUBJECTS WITH GEOGRAPHIC ATROPHY SECONDARY TO DRY AGE-RELATED MACULAR DEGENERATION
NREC Code:
21-NREC-CT-129
Decision:
Favourable
Meeting Date:
03/11/2021
Study Type:
CT application
Principal Investigator:
Dr Eugene Ng
PI Institution:
Institute of Eye Surgery, UPMC Whitfield Hospital, Butlerstown, Waterford, X91 DH9W, Ireland
Sponsor:
Gyroscope Therapeutics